PubMed Central (PMC) Search Page
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 2020 | 153 |
| 2021 | 153 |
| 2022 | 113 |
| 2023 | 28 |
| 2024 | 18 |
| 2026 | 0 |
-
Publication date
-
-
Publication stage
These filters represent the three primary types of content included in the PMC archive: 1) content published in a scholarly journal 2) peer-reviewed author manuscripts accepted for publication in a journal and 3) preprint versions of articles collected through the NIH Preprint Pilot, made public prior to peer review
-
-
Collections
The PMC Open Access Subset includes journal articles and preprints that are made available under license terms that allow reuse. Historical back issues refers to digitized content from print journals made available in PMC through the Biomedical Journal Digitization Projects.
-
"nejm group covid 19 collection"[Filter]
The embargo is the time during which the publisher retains exclusive rights to distribute articles. Those articles are made freely available on the PMC website after the embargo period has ended. Citations for articles under an embargo period will still display in the PMC results list by default. Choose “Exclude” to prevent embargoed articles from displaying in your results.
-
Oral Nirmatrelvir-Ritonavir as Postexposure Prophylaxis for Covid-19.
- Hammond J, Yunis C, Fountaine RJ, Luscan G, Burr AM, Zhang W, Wisemandle W, Soares H, Baniecki ML, Hendrick VM, Kalfov V, Pypstra R, Rusnak JM.
- N Engl J Med. 2024 Jul 18;391(3):224-234. doi: 10.1056/NEJMoa2309002.
- PMCID: PMC11694828
Hammond J, et al.N Engl J Med. 2024.PMCID: PMC11694828 -
Activity of Research-Grade Pemivibart against Recent SARS-CoV-2 JN.1 Sublineages.
- Wang Q, Guo Y, Ho J, Ho DD.
- N Engl J Med. 2024 Nov 14;391(19):1863-1864. doi: 10.1056/NEJMc2410203.
- PMCID: PMC11687644
Wang Q, et al.N Engl J Med. 2024.PMCID: PMC11687644 -
Immunobridging for Pemivibart, a Monoclonal Antibody for Prevention of Covid-19.
- Schmidt P, Li Y, Popejoy M.
- N Engl J Med. 2024 Nov 14;391(19):1860-1862. doi: 10.1056/NEJMc2404555.
- PMCID: PMC11687646
Schmidt P, et al.N Engl J Med. 2024.PMCID: PMC11687646 -
Long Covid Defined.
- Ely EW, Brown LM, Fineberg HV; National Academies of Sciences, Engineering, and Medicine Committee on Examining the Working Definition for Long Covid.
- N Engl J Med. 2024 Jul 31;391(18):1746-1753. doi: 10.1056/NEJMsb2408466.
- PMCID: PMC11687645
Ely EW, et al.N Engl J Med. 2024.PMCID: PMC11687645 -
Postacute Sequelae of SARS-CoV-2 Infection in the Pre-Delta, Delta, and Omicron Eras.
- Xie Y, Choi T, Al-Aly Z.
- N Engl J Med. 2024 Jul 17;391(6):515-525. doi: 10.1056/NEJMoa2403211.
- PMCID: PMC11687648
Xie Y, et al.N Engl J Med. 2024.PMCID: PMC11687648 -
Cognition and Memory after Covid-19 in a Large Community Sample.
- Buonsenso D.
- N Engl J Med. 2024 Jun 6;390(21):2034. doi: 10.1056/NEJMc2403996.
- PMCID: PMC11687643
Buonsenso D.N Engl J Med. 2024.PMCID: PMC11687643 -
Plugging Public Health Data into the Health IT Ecosystem to Protect National Health.
- Layden JE, Swain MJ, Brennan N, Tripathi M.
- NEJM Catal Innov Care Deliv. 2024 Jul 17;5(8):CAT.24.0129. doi: 10.1056/CAT.24.0129.
- PMCID: PMC11254350
Layden JE, et al.NEJM Catal Innov Care Deliv. 2024.PMCID: PMC11254350 -
Knocking Down Public Health and Health Care Silos: An Innovative Covid-19 Health Equity Response.
- Johansen I, Selim M, Jackson M, Rattray CR.
- NEJM Catal Innov Care Deliv. 2024 Jul 17;5(8):CAT.24.0118. doi: 10.1056/CAT.24.0118.
- PMCID: PMC11254351
Johansen I, et al.NEJM Catal Innov Care Deliv. 2024.PMCID: PMC11254351 -
False Positive Covid-19 Rapid Antigen Tests.
- Yang C, Espín E, Tebbutt SJ.
- N Engl J Med. 2024 May 16;390(19):1835-1836. doi: 10.1056/NEJMc2403409.
- PMCID: PMC11156229
Yang C, et al.N Engl J Med. 2024.PMCID: PMC11156229 -
Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19.
- Moser CB, Li JZ, Hughes MD.
- N Engl J Med. 2024 Apr 25;390(16):1533-1534. doi: 10.1056/NEJMc2402378.
- PMCID: PMC11156227
Moser CB, et al.N Engl J Med. 2024.PMCID: PMC11156227